CN Stock MarketDetailed Quotes
301009 Hangzhou Coco Healthcare Products
- 9.59
- +0.04+0.42%
Market Closed Nov 29 15:00 CST
2.61BMarket Cap174.36P/E (TTM)
9.82High9.46Low52.96KlotVolume9.67Open9.55Pre Close50.95MTurnover4.06%Turnover Ratio129.59P/E (Static)271.86MShares11.4152wk High1.94P/B1.25BFloat Cap6.7352wk Low11.46Limit Up130.56MShs Float38.08Historical High7.64Limit Down3.77%Amplitude6.73Historical Low0.08Dividend TTM9.62Avg Price28.39KlotAsk0.78%Div YieldTTM100Lot Size22.65KlotBid
Hangzhou Coco Healthcare Products Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -10.81%828.62M | -13.83%556.34M | -12.14%269.78M | 1.37%1.24B | 8.03%929.1M | 21.05%645.67M | 25.22%307.05M | -7.13%1.22B | -13.13%860.06M | -21.03%533.38M |
| Refunds of taxes and levies | 20.73%31.57M | 61.94%26.07M | 131.61%16.77M | -54.58%33.09M | -54.04%26.15M | -62.49%16.1M | -57.40%7.24M | 16.34%72.86M | 19.54%56.9M | 35.68%42.92M |
| Cash received relating to other operating activities | 33.78%67.54M | 32.17%56.05M | 21.69%37.04M | -50.26%58.86M | -54.20%50.49M | -57.22%42.41M | -44.95%30.43M | -16.03%118.34M | -21.69%110.24M | -24.59%99.12M |
| Cash inflows from operating activities | -7.76%927.74M | -9.33%638.46M | -6.13%323.59M | -5.85%1.33B | -2.09%1.01B | 4.26%704.17M | 8.58%344.73M | -6.99%1.41B | -12.83%1.03B | -19.45%675.42M |
| Goods services cash paid | 2.03%670.88M | 0.11%464.98M | -11.52%218.25M | -29.74%860.59M | -19.13%657.52M | -6.93%464.45M | 5.56%246.67M | 4.49%1.22B | -8.10%813.01M | -15.37%499.06M |
| Staff behalf paid | 7.10%80.8M | 0.83%53.83M | 15.85%29.72M | -12.02%99.27M | -3.84%75.44M | -0.33%53.38M | -6.73%25.66M | 3.01%112.83M | 4.65%78.46M | 1.39%53.56M |
| All taxes paid | -10.63%17.39M | -6.50%14.12M | 28.11%8.26M | 64.88%20.96M | -23.02%19.46M | -30.35%15.11M | -33.88%6.45M | -75.56%12.72M | -61.41%25.28M | -43.97%21.69M |
| Cash paid relating to other operating activities | 32.06%120.7M | 24.83%89.47M | 18.58%53.62M | 22.65%119.89M | -26.06%91.4M | -31.45%71.67M | -38.11%45.22M | -26.33%97.75M | -24.73%123.62M | -24.88%104.56M |
| Cash outflows from operating activities | 5.45%889.77M | 2.94%622.41M | -4.37%309.85M | -23.99%1.1B | -18.89%843.82M | -10.94%604.61M | -5.82%324M | -1.25%1.45B | -12.53%1.04B | -17.25%678.86M |
| Net cash flows from operating activities | -76.55%37.97M | -83.87%16.06M | -33.76%13.73M | 712.05%227.7M | 1,329.19%161.92M | 2,990.04%99.56M | 178.19%20.73M | -173.63%-37.2M | -19.69%-13.17M | -119.03%-3.44M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --553.05M | ---- | ---- | ---- | ---- | ---- | ---- | -69.77%65M | -45.83%65M | -45.84%65M |
| Cash received from returns on investments | --1.22M | ---- | ---- | ---- | ---- | ---- | ---- | -95.36%235.09K | -86.95%235.09K | -86.75%235.09K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 2,601.81%6M | 2,760.22%6M | 7,666,566.67%4.6M | 13.14%685.25K | -63.21%222.07K | 249.62%209.77K | -99.54%60 | 29.69%605.65K | 433.03%603.65K | --60K |
| Cash received relating to other investing activities | ---- | ---- | ---- | 42.47%4.87M | --2.8M | --2.8M | ---- | --3.42M | ---- | ---- |
| Cash inflows from investing activities | 18,415.49%560.27M | 99.09%6M | 7,666,566.67%4.6M | -91.98%5.56M | -95.40%3.03M | -95.38%3.01M | -99.98%60 | -68.59%69.26M | -46.00%65.84M | -46.39%65.3M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 21.98%64.92M | 14.76%44.7M | 39.86%28.53M | -43.29%66.01M | -45.94%53.22M | -41.69%38.95M | -65.14%20.4M | -51.59%116.4M | -53.79%98.45M | -56.87%66.79M |
| Cash paid to acquire investments | 6,936.44%743.05M | 3,081.82%210M | ---- | -83.75%10.56M | -83.75%10.56M | -89.85%6.6M | --16.6M | -31.58%65M | -75.93%65M | --65M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --2.23M | -93.92%1.82M | ---- | ---- | ---- | --30M | ---- |
| Cash outflows from investing activities | 1,131.54%807.97M | 459.18%254.7M | -22.89%28.53M | -56.56%78.8M | -66.09%65.61M | -65.44%45.55M | -36.77%37M | -45.92%181.4M | -59.95%193.45M | -14.90%131.79M |
| Net cash flows from investing activities | -295.81%-247.7M | -484.70%-248.7M | 35.32%-23.93M | 34.68%-73.25M | 50.96%-62.58M | 36.04%-42.53M | 36.50%-37M | 2.42%-112.14M | 64.66%-127.61M | -101.07%-66.5M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 100.00%200K | 100.00%200K | 100.00%200K | --100K | --100K | --100K | --100K | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 100.00%200K | 100.00%200K | 100.00%200K | --100K | --100K | --100K | --100K | ---- | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | --3.05M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | --10M | --3.05M | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -93.66%200K | 100.00%200K | 100.00%200K | --13.15M | --3.15M | --100K | --100K | ---- | ---- | ---- |
| Borrowing repayment | --450K | --450K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | --20.07M | ---- | ---- | ---- | ---- | ---- | ---- | 2,055.96%19.03M | 2,055.96%19.03M | 2,310.11%19.03M |
| Cash payments relating to other financing activities | 157.11%33.09M | 176.02%32.55M | --31.36M | -58.64%12.76M | --12.87M | --11.79M | ---- | 1,270.67%30.84M | ---- | ---- |
| Cash outflows from financing activities | 316.55%53.61M | 179.84%33M | --31.36M | -74.42%12.76M | -32.36%12.87M | -38.02%11.79M | ---- | -67.24%49.87M | -89.61%19.03M | -81.87%19.03M |
| Net cash flows from financing activities | -449.67%-53.41M | -180.52%-32.8M | -31,257.19%-31.16M | 100.80%396.75K | 48.94%-9.72M | 38.55%-11.69M | --100K | -107.29%-49.87M | -102.78%-19.03M | -102.49%-19.03M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -181.31%-2.16M | 9.97%2.51M | 260.88%1.72M | -49.68%2.14M | -51.05%2.66M | 20.52%2.28M | -889.40%-1.07M | 260.37%4.24M | 373.94%5.44M | 188.13%1.89M |
| Net increase in cash and cash equivalents | -387.51%-265.31M | -652.23%-262.94M | -129.92%-39.63M | 180.52%156.99M | 159.78%92.28M | 154.68%47.61M | 79.69%-17.24M | -131.61%-194.97M | -149.59%-154.38M | -111.67%-87.08M |
| Add:Begin period cash and cash equivalents | 24.55%796.44M | 24.55%796.44M | 24.55%796.44M | -23.37%639.45M | -23.37%639.45M | -23.37%639.45M | -23.37%639.45M | 283.39%834.42M | 283.39%834.42M | 283.39%834.42M |
| End period cash equivalent | -27.41%531.13M | -22.35%533.51M | 21.63%756.81M | 24.55%796.44M | 7.60%731.73M | -8.07%687.07M | -16.99%622.22M | -23.37%639.45M | 28.57%680.05M | -22.48%747.35M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data